$UAMY

Marinelli Jon R purchased $93K of UAMY

Marinelli Jon R purchased 12,500 shares of UNITED STATES ANTIMONY CORP (UAMY) at $7.45 on 2026-06-15.

Original reporting
SEC EDGAR · Marinelli Jon R
Published Jun 17, 2026, 5:51 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 17, 2026, 5:55 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$UAMY
Bullish
low confidence
Mentioned
$UAMY
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$UAMYBullishLow
01

Why it matters

The newest fact is the director’s open-market purchase (12,500 shares at $7.45) disclosed via EDGAR on 2026-06-17.

02

Market read

Traders may note mild sentiment support from insider buying, but there’s no fundamental update to underwrite a directional trade.

03

What to watch

The article doesn’t state whether the purchase was part of a broader pattern, whether other insiders bought/sold, or whether the company has upcoming catalysts that would make the buy more informative.

Relevance 4/10Novelty 6/10Timing: SEC Form 4 filed 2026-06-17 (covering 2026-06-15 purchase)

Background

The article is an SEC Form 4 insider transaction disclosure for United States Antimony Corp (UAMY).

Company-level read

Ticker impact

$UAMYBullishLow confidence
Context

Marinelli Jon R (director) filed an open-market purchase of 12,500 shares at $7.45 on 2026-06-15, totaling $93,125.

Expected impact

Likely limited near-term impact; any effect should be small and fade unless followed by additional disclosures.

Evidence & confidence

The filing is a Form 4 insider purchase with relatively small dollar value and no accompanying operational/regulatory/financial change disclosed.

Market effects

No sector read-across; this is a single-company insider transaction with no stated business development.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine or driven by personal liquidity/compensation mechanics; without a 10b5-1 plan or additional context, signal strength is weak.

Key entities

  • United States Antimony Corp

    Subject of the Form 4 insider transaction; director Marinelli Jon R purchased 12,500 shares at $7.45.

  • Marinelli Jon R

    Director who reported an open-market purchase totaling $93,125; no pre-arranged 10b5-1 plan indicated.

Related articles

$UAMYMed

Why Shares of United States Antimony Are Soaring This Week

United States Antimony (UAMY) shares rose about 12.2% from last Friday to 1:21 p.m. after the company reported completing initial Q2 2026 shipments under a $245M Defense Logistics Agency supply contract. It delivered ~82,000 pounds of antimony ingots, generating ~$2.6M, and is awaiting inspections for two more shipments. UAMY has received $57.3M in orders since contract start.

$UAMYMed

United States Antimony Corp.: United States Antimony Corporation Provides Update on Antimony Shipments to the DoW

United States Antimony Corp. (NYSE:UAMY) said it delivered the first shipments in Q2 2026 under a $245 million Defense Logistics Agency (DLA) supply contract. It shipped ~82,000 pounds of antimony metal ingots, generating about $2.6 million in June invoices. Total DLA orders since contract start are $57.3 million; two more shipments await inspection and authorization.

$USASMedAI 9/10

Americas extends hot streak with Cosalá hits

Americas Gold and Silver said new Cosalá infill drill results, reported after an Oct. 31 cutoff, returned grades up to 5x above its resource model at San Rafael Upper and 120 zones and are feeding mine planning for the second half. Examples include SR568 (14m of 599.8 g/t silver, 0.83% Cu) and 120-25-G95 (45m of 342.9 g/t silver, 0.85% Cu). The company also budgeted ~$20m for a 64,000m drill program.

$UAMYMedAI 8/10

I'm Thinking About Pulling the Trigger on This Producer of a Mineral Deemed "Critical" to the U.S.

The article says U.S. demand for antimony—classified by the U.S. as a critical mineral—has driven investor interest as the U.S. imports about 90% of its needs, while China is the largest producer. United States Antimony (UAMY) reported weaker first-quarter results, with revenue declining and a loss. It secured a federal sole-source contract worth up to $245 million, with a $10 million initial order, and had $39 million revenue in 2025.

$UAMYMedAI 8/10

I'm Thinking About Pulling the Trigger on This Producer of a Mineral Deemed "Critical" to the U.S.

The article says U.S. Antimony (NYSE: UAMY) is gaining investor attention as the U.S. seeks alternatives to China for “critical” minerals. It cites antimony’s military and semiconductor uses and notes the company’s first-quarter results showed revenue decline and a loss. U.S. Antimony received a sole-source federal contract worth up to $245 million, with $10 million initially ordered, and reported $39 million revenue in 2025.